Home › Funds › SYSTEMATIC FINANCIAL MANAGEMENT LP › EXEL
SYSTEMATIC FINANCIAL MANAGEMENT LP position in EXEL
EXELIXIS INC · Health Care
SYSTEMATIC FINANCIAL MANAGEMENT LP reported holding 649,980 shares of EXEL (EXELIXIS INC) in its Q2 2026 13F filing — a position valued at US$35.4M, representing 0.70% of its reported portfolio and ranking #47 among its reported holdings. SYSTEMATIC FINANCIAL MANAGEMENT LP has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SYSTEMATIC FINANCIAL MANAGEMENT LP's EXEL position evolved
SYSTEMATIC FINANCIAL MANAGEMENT LP first disclosed a stake in EXEL in Q3 2023 at 1,151,818 shares (US$25.2M). The position peaked in Q2 2025 at 1,115,619 shares, worth US$49.2M. Across 12 filings, SYSTEMATIC FINANCIAL MANAGEMENT LP increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 649,980 shares valued at US$35.4M — a reduction of -59,147 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.15M | $25.17M | New |
| Q4 2023 | 1.14M | $27.24M | Reduce |
| Q1 2024 | 1.13M | $26.84M | Hold |
| Q2 2024 | 1.09M | $24.51M | Reduce |
| Q3 2024 | 1.17M | $30.32M | Add |
| Q4 2024 | 1.16M | $38.77M | Hold |
| Q1 2025 | 1.13M | $41.84M | Reduce |
| Q2 2025 | 1.12M | $49.17M | Reduce |
| Q3 2025 | 1.10M | $45.23M | Reduce |
| Q4 2025 | 987.31K | $43.27M | Reduce |
| Q1 2026 | 709.13K | $30.41M | Reduce |
| Q2 2026 | 649.98K | $35.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 42 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M), Renaissance Technologies (US$730.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.93M sh · $485.85M · Q2 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- Stephens Investment Management Group LLC 2.71M sh · $147.45M · Q2 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on SYSTEMATIC FINANCIAL MANAGEMENT LP
FAQ
How long has SYSTEMATIC FINANCIAL MANAGEMENT LP held EXEL?
SYSTEMATIC FINANCIAL MANAGEMENT LP has disclosed EXEL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SYSTEMATIC FINANCIAL MANAGEMENT LP's current position in EXEL?
As of Q2 2026, SYSTEMATIC FINANCIAL MANAGEMENT LP holds 649.98K shares of EXEL (EXELIXIS INC), valued at $35.37M, representing 0.70% of its reported portfolio and ranking #47.
Has SYSTEMATIC FINANCIAL MANAGEMENT LP been buying or selling EXEL?
In the latest 13F filing (Q2 2026), SYSTEMATIC FINANCIAL MANAGEMENT LP reduced its position in EXEL. The position peaked in Q2 2025 at 1.12M shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.